Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Byers

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Reproductive Biomedicine Online|July 25, 2016
Association of a promoter polymorphism in FSHR with ovarian reserve and response to ovarian stimulation in women undergoing assisted reproductive treatmentDalia Tohlob, Ekbal Abo Hashem, Nawal Ghareeb, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 29, 2013
Increased rate of phenocopies in all age groups in BRCA1/BRCA2 mutation kindred, but increased prospective breast cancer risk is confined to BRCA2 mutation carriersD Gareth R Evans, Sarah L Ingham, Iain Buchan, et al.
European Journal of Human Genetics : EJHG|June 9, 2016
Sensitivity of BRCA1/2 testing in high-risk breast/ovarian/male breast cancer families: little contribution of comprehensive RNA/NGS panel testingHelen Byers, Yvonne Wallis, Elke M van Veen, et al.
Breast Cancer Research and Treatment|July 13, 2016
Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trialsAdam R Brentnall, Jack Cuzick, Helen Byers, et al.
Proteomics|July 27, 2004
Effect of high-fat diet on the expression of proteins in muscle, adipose tissues, and liver of C57BL/6 miceGerhard M Schmid, Véronique Converset, Nadia Walter, et al.
International Journal of Cancer|August 30, 2021
The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?D Gareth Evans, Elke M van Veen, Helen Byers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention TrialsJack Cuzick, Adam R Brentnall, Corrinne Segal, et al.
JAMA Oncology|January 19, 2018
Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk PredictionElke M van Veen, Adam R Brentnall, Helen Byers, et al.
International Journal of Cancer|June 29, 2019
A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic densityAdam R Brentnall, Elke M van Veen, Elaine F Harkness, et al.
Breast Cancer Research and Treatment|April 4, 2019
Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variantsD Gareth R Evans, Elaine F Harkness, Adam R Brentnall, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Reproductive Biomedicine Online|July 25, 2016
Association of a promoter polymorphism in FSHR with ovarian reserve and response to ovarian stimulation in women undergoing assisted reproductive treatmentDalia Tohlob, Ekbal Abo Hashem, Nawal Ghareeb, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 29, 2013
Increased rate of phenocopies in all age groups in BRCA1/BRCA2 mutation kindred, but increased prospective breast cancer risk is confined to BRCA2 mutation carriersD Gareth R Evans, Sarah L Ingham, Iain Buchan, et al.
European Journal of Human Genetics : EJHG|June 9, 2016
Sensitivity of BRCA1/2 testing in high-risk breast/ovarian/male breast cancer families: little contribution of comprehensive RNA/NGS panel testingHelen Byers, Yvonne Wallis, Elke M van Veen, et al.
Breast Cancer Research and Treatment|July 13, 2016
Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trialsAdam R Brentnall, Jack Cuzick, Helen Byers, et al.
Proteomics|July 27, 2004
Effect of high-fat diet on the expression of proteins in muscle, adipose tissues, and liver of C57BL/6 miceGerhard M Schmid, Véronique Converset, Nadia Walter, et al.
International Journal of Cancer|August 30, 2021
The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?D Gareth Evans, Elke M van Veen, Helen Byers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention TrialsJack Cuzick, Adam R Brentnall, Corrinne Segal, et al.
JAMA Oncology|January 19, 2018
Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk PredictionElke M van Veen, Adam R Brentnall, Helen Byers, et al.
International Journal of Cancer|June 29, 2019
A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic densityAdam R Brentnall, Elke M van Veen, Elaine F Harkness, et al.
Breast Cancer Research and Treatment|April 4, 2019
Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variantsD Gareth R Evans, Elaine F Harkness, Adam R Brentnall, et al.
Pageof 3